Galectin-3 in heart failure patients: marker or mediator of renal insufficiency?

被引：0
|
作者：
Zamora, E. [1 ]
Lupon, J. [1 ]
De Antonio, M. [1 ]
Galan, A. [1 ]
Domingo, M. [1 ]
Urrutia, A. [1 ]
Gonzalez, B. [1 ]
Diez, C. [1 ]
Troya, M. [1 ]
Bayes-Genis, A. [1 ]
机构：
[1] Germans Trias & Pujol Univ Hosp, Badalona, Spain
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
86
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [31] Renal Handling of Galectin-3 in the General Population, Chronic Heart Failure, and Hemodialysis
    Meijers, Wouter C.
    van der Velde, A. Rogier
    Ruifrok, Willem P.
    Schroten, Nicolas F.
    Dokter, Martin M.
    Damman, Kevin
    Assa, Solmaz
    Franssen, Casper F.
    Gansevoort, Ron T.
    van Gilst, Wiek H.
    Sillje, Herman H.
    de Boer, Rudolf A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (05):
  • [32] Galectin-3: clinical utility and prognostic value in patients with heart failure
    Kramer, Frank
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2013, 4 : 13 - 22
  • [33] Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
    van den Berg, Pieter F.
    Aboumsallem, Joseph Pierre
    Screever, Elles M.
    Shi, Canxia
    de Wit, Sanne
    Bracun, Valentina
    Yousif, Laura I.
    Geerlings, Lotte
    Wang, Dongyu
    Ho, Jennifer E.
    Bakker, Stephan J. L.
    van der Vegt, Bert
    Sillje, Herman H. W.
    de Boer, Rudolf A.
    Meijers, Wouter C.
    JACC: CARDIOONCOLOGY, 2023, 5 (04): : 445 - 453
  • [34] Galectin-3 as a New Remodeling Marker in Heart Failure: Comparison to Other Neurohumoral Biomarkers
    Gruson, Damien
    Ahn, Sylvie A.
    Ketelslegers, Jean-Marie
    Rousseau, Michel F.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S25 - S25
  • [35] Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study
    Oikonomou, Evangelos
    Karlis, Dimitris
    Tsalamadris, Sotiris
    Siasos, Gerasimos
    Chrysohoou, Christina
    Vogiatzi, Georgia
    Dimitropoulos, Stathis
    Charalambous, Georgios
    Kouskouni, Evangelia
    Tousoulis, Dimitris
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (04) : 396 - 400
  • [36] The dynamics of galectin-3 in patients with heart failure and preserved ejection fraction
    Kushnir, Y. Yulia
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 415 - 416
  • [37] The association of galectin-3 and clinical parameters in patients with chronic heart failure
    Gyamdjyan, K. Karine
    Maximov, M. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 490 - 491
  • [38] Predictors of galectin-3 in patients with heart failure and reduced ejection fraction
    Alexanian, I.
    Parisis, I.
    Bistola, V.
    Bakosis, G.
    Cholevas, N.
    Tzifi, F.
    Karamichalakis, N.
    Niarchou, P.
    Xydonas, S.
    Pappas, L.
    Letsas, K.
    Efremidis, M.
    Sideris, A.
    Filippatos, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 561 - 561
  • [39] Galectin-3, oxidative stress and endotoxemia in patients with chronic heart failure
    Medvedeva, E. A. Elena
    Shchukin, Y. V.
    Surkova, E. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 214 - 214
  • [40] RELATIONSHIP OF GALECTIN-3 WITH HEMODYNAMIC PARAMETERS OF PATIENTS WITH CHRONIC HEART FAILURE
    Nurillaeva, N. M.
    Qurbonov, A. K.
    Nasretdenova, D. O.
    ATHEROSCLEROSIS, 2021, 331 : E235 - E235
12345